Companion
First Edition
Microbiology
CLSI MR15
Piperacillin-Tazobactam Breakpoints for Pseudomonas aeruginosa
CLSI MR15 is a rationale document featuring CLSI Working Group compiled data on Piperacillin-Tazobactam. This document assists in reassessing piperacillin-tazobactam breakpoints against Pseudomonas aeruginosa.
This edition of the document was corrected in February 2024. Read the correction notices by accessing the link above, and learn more about our correction process here.
January 02, 2024
Romney M. Humphries, PhD, D(ABMM), FIDSA; Pranita D. Tamma, MD, MHS
{{FormatPrice(currentPrice)}}
Free
{{FormatPrice(nonMemberPrice)}} List PriceThis is your member pricing.
Notify Me About New Editions
Product Details
MR15Ed1E
978-1-68440-212-0
12
Additional Details
This document is available in electronic format only.
Additional Details
This document is available in electronic format only.